![Young Kwon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Young Kwon
Directeur/Membre du Conseil chez
ADMA BIOLOGICS, INC.
Fortune : 2 M $ au 31/05/2026
Profil
Young T.
Kwon is an Independent Director at ADMA Biologics, Inc. since 2021 and an Advisor at LSV Capital Management LLC since 2021.
Former roles include Chief Executive Officer & Director at Alchemab Therapeutics Ltd. from 2022 to 2024, Senior Director-Business Development at Biogen Idec, Inc. (North Carolina), Chief Financial & Business Officer at Momenta Pharmaceuticals, Inc. from 2020 to 2021, and Senior Associate at ATV Capital Management Inc. from 2003 to 2005.
Education includes a doctorate from Harvard University conferred in 1999 and an undergraduate degree from the Massachusetts Institute of Technology conferred in 1994.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ADMA BIOLOGICS, INC. 0,11 % | 31/03/2026 | 252 330 ( 0,11 % ) | 2 M $ | 31/05/2026 |
Postes actifs de Young Kwon
| Sociétés | Poste | Début |
|---|---|---|
| ADMA BIOLOGICS, INC. | Directeur/Membre du Conseil | 15/10/2021 |
LSV CAPITAL MANAGEMENT LLC
 LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Consultant / Advisor | 01/04/2021 |
Anciens postes connus de Young Kwon
| Sociétés | Poste | Fin |
|---|---|---|
Alchemab Therapeutics Ltd.
 Alchemab Therapeutics Ltd. BiotechnologyHealth Technology Engages in developing of antibodies | Directeur Général | 12/09/2024 |
| MOMENTA PHARMACEUTICALS, INC. | Directeur Financier/CFO | 01/01/2021 |
ATV Capital Management Inc.
 ATV Capital Management Inc. Investment ManagersFinance ATV Capital Management invests in private companies located in the United States. The firm focuses on information technology, healthcare, and cleantech. It participates in early stage transactions. | Analyste en capital-investissement | 31/12/2005 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | - |
Formation de Young Kwon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
92
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
ADMA Biologics, Inc.
 ADMA Biologics, Inc. BiotechnologyHealth Technology Develops, manufactures and markets specialty biologics | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ATV Capital Management Inc.
ATV Capital Management Inc. Investment ManagersFinance ATV Capital Management invests in private companies located in the United States. The firm focuses on information technology, healthcare, and cleantech. It participates in early stage transactions. | Finance |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
LSV CAPITAL MANAGEMENT LLC
LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Alchemab Therapeutics Ltd.
Alchemab Therapeutics Ltd. BiotechnologyHealth Technology Engages in developing of antibodies | Health Technology |
